Back to School: How biopharma can reboot drug development. Access exclusive analysis here
In the double-blind, placebo-controlled Phase III AVITA trial (BO17706) in 607 patients with metastatic pancreatic
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury